BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 22075577)

  • 1. Using pathway modules as targets for assay development in xenobiotic screening.
    Judson RS; Mortensen HM; Shah I; Knudsen TB; Elloumi F
    Mol Biosyst; 2012 Feb; 8(2):531-42. PubMed ID: 22075577
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Computational toxicology as implemented by the U.S. EPA: providing high throughput decision support tools for screening and assessing chemical exposure, hazard and risk.
    Kavlock R; Dix D
    J Toxicol Environ Health B Crit Rev; 2010 Feb; 13(2-4):197-217. PubMed ID: 20574897
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bioinformatic approach to identify chaperone pathway relationship from large-scale interaction networks.
    Gong Y; Zhang Z; Houry WA
    Methods Mol Biol; 2011; 787():189-203. PubMed ID: 21898237
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cellular stress response pathway system as a sentinel ensemble in toxicological screening.
    Simmons SO; Fan CY; Ramabhadran R
    Toxicol Sci; 2009 Oct; 111(2):202-25. PubMed ID: 19567883
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estimating toxicity-related biological pathway altering doses for high-throughput chemical risk assessment.
    Judson RS; Kavlock RJ; Setzer RW; Hubal EA; Martin MT; Knudsen TB; Houck KA; Thomas RS; Wetmore BA; Dix DJ
    Chem Res Toxicol; 2011 Apr; 24(4):451-62. PubMed ID: 21384849
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Technology evaluation: SAGE, Genzyme molecular oncology.
    Bartlett J
    Curr Opin Mol Ther; 2001 Feb; 3(1):85-96. PubMed ID: 11249736
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A framework to identify physiological responses in microarray-based gene expression studies: selection and interpretation of biologically relevant genes.
    Rodenburg W; Heidema AG; Boer JM; Bovee-Oudenhoven IM; Feskens EJ; Mariman EC; Keijer J
    Physiol Genomics; 2008 Mar; 33(1):78-90. PubMed ID: 18162501
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety and nutritional assessment of GM plants and derived food and feed: the role of animal feeding trials.
    EFSA GMO Panel Working Group on Animal Feeding Trials
    Food Chem Toxicol; 2008 Mar; 46 Suppl 1():S2-70. PubMed ID: 18328408
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The opportunities and challenges of personalized genome-based molecular therapies for cancer: targets, technologies, and molecular chaperones.
    Workman P
    Cancer Chemother Pharmacol; 2003 Jul; 52 Suppl 1():S45-56. PubMed ID: 12819933
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systems toxicology and the Chemical Effects in Biological Systems (CEBS) knowledge base.
    Waters M; Boorman G; Bushel P; Cunningham M; Irwin R; Merrick A; Olden K; Paules R; Selkirk J; Stasiewicz S; Weis B; Van Houten B; Walker N; Tennant R
    EHP Toxicogenomics; 2003 Jan; 111(1T):15-28. PubMed ID: 12735106
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel trends in high-throughput screening.
    Mayr LM; Bojanic D
    Curr Opin Pharmacol; 2009 Oct; 9(5):580-8. PubMed ID: 19775937
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gene expression analysis in clear cell renal cell carcinoma using gene set enrichment analysis for biostatistical management.
    Maruschke M; Reuter D; Koczan D; Hakenberg OW; Thiesen HJ
    BJU Int; 2011 Jul; 108(2 Pt 2):E29-35. PubMed ID: 21435154
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantifying modularity in the evolution of biomolecular systems.
    Snel B; Huynen MA
    Genome Res; 2004 Mar; 14(3):391-7. PubMed ID: 14993205
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biomarkers in aquatic plants: selection and utility.
    Brain RA; Cedergreen N
    Rev Environ Contam Toxicol; 2009; 198():49-109. PubMed ID: 19253039
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of high-throughput screening for in vitro micronucleus test using fluorescence-based cell imaging.
    Shibai-Ogata A; Kakinuma C; Hioki T; Kasahara T
    Mutagenesis; 2011 Nov; 26(6):709-19. PubMed ID: 21745803
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cheminformatics approaches to analyze diversity in compound screening libraries.
    Akella LB; DeCaprio D
    Curr Opin Chem Biol; 2010 Jun; 14(3):325-30. PubMed ID: 20457001
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Advancing exposure characterization for chemical evaluation and risk assessment.
    Cohen Hubal EA; Richard A; Aylward L; Edwards S; Gallagher J; Goldsmith MR; Isukapalli S; Tornero-Velez R; Weber E; Kavlock R
    J Toxicol Environ Health B Crit Rev; 2010 Feb; 13(2-4):299-313. PubMed ID: 20574904
    [TBL] [Abstract][Full Text] [Related]  

  • 19. General approach to identifying potential targets for cancer imaging by integrated bioinformatics analysis of publicly available genomic profiles.
    Yang Y; Adelstein SJ; Kassis AI
    Mol Imaging; 2011 Apr; 10(2):123-34. PubMed ID: 21439257
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recent progress in biomolecular engineering.
    Ryu DD; Nam DH
    Biotechnol Prog; 2000; 16(1):2-16. PubMed ID: 10662483
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.